AR and hypogonadotropic hypogonadism: BPA can also bind to the androgen receptor (AR) as an antagonist [11], which can disrupt the hypothalamic-pituitary-testicular axis, thereby affecting gene expression and the enzymatic activity of testicular steroidogenesis, leading to hypogonadotropic hypogonadism [12, 13].